Teras LR, DeSantis CE, Cerhan JR, et al: US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66: 443, 2016.
Blume P, Charlot-Hicks F, Mohammed S: Case report and review of primary bone diffuse large B-cell lymphoma involving the calcaneus. J Foot Ankle Surg 52: 666, 2013.
Mariano A, Fallat LM: Unusual presentation of diffuse large B-cell lymphoma involving the calcaneus: a case report. Foot Ankle Surg Techniq Rep Cases 1: 100102, 2021.
Mendeszoon MJ, Wire KR: Diffuse large B-cell lymphoma of the ankle: a case study of surgical intervention and outcome. JAPMA 100: 505, 2010.
Litwic A, Sampson M, Foria V, et al: Diffuse large B cell lymphoma of the foot in a patient with rheumatoid arthritis. EMJ Rheumatol 2: 84, 2015.
Park I, Kang S: Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and F-fluorodeoxyglucose positron emission tomography/computed tomography: a case report. J Med Case Rep 11: 89, 2017.
Bulut N, Arslan HS, Ozaydın IY: Diffuse large B-cell lymphoma involvement in two different localizations: a case report. Surg J (NY) 5: e14, 2019.
Kheder EM, Sharahlii HH, AlSubaie SM, et al: Diffuse large B-cell lymphoma mimicking chronic osteomyelitis of the ankle joint: a case report. SAGE Open Med Case Rep 9: 1, 2021.
Oberoi M, Perinkulam Sathyanarayanan S, Akther J, et al: Diffuse large B-cell lymphoma of the tibia in a patient with longstanding seropositive rheumatoid arthritis on methotrexate. Cureus 14: e23232, 2022.
Kahraman S, Sabuncuoglu H, Gunhan O, et al: A rare reason of foot drop caused by primary diffuse large B-cell lymphoma of the sciatic nerve: case report. Acta Neurochir 152: 125, 2010.
Moussa A, Chakhachiro Z, Sawaya RA: Posterior tibial nerve lymphoma presenting as tarsal tunnel syndrome: a case report. J Foot Ankle Surg 57: 167, 2018.
Ibrahim S, Jain A, Pai K: A case of false identity: primary cutaneous diffuse large B-cell lymphoma masquerading as Madura Foot. Trop Doct 51: 617, 2021.
Kelly J, Mirkin G, Yim J, et al: Primary cutaneous diffuse large B-cell lymphoma, leg type on the dorsal foot in a senior woman: a case report. JAPMA 112: 21, 2022.
Huchital M, Hoda ST, Delmonte R, et al: Metastasis of cutaneous B-cell lymphoma affecting the metatarsal head: a case report. JAPMA 111: Article_20, 2021.
Castillo JJ, Ingham RR, Reagan JL, et al: Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk 14: 122, 2014.
Zhao J, Su L, Zhong J: Risk factors for cancer-specific mortality and cardiovascular mortality in patients with diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk 20: e858, 2020.
Grange F, Beylot-Barry M, Courville P, et al: Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol 143: 1144, 2007.
Laurent C, Ram-Wolff C, Ingen-Housz-Oro S, et al: Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type. Clin Exp Dermatol 48: 116, 2023.
Fox CP, Phillips EH, Smith J, et al: Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol 184: 348, 2019.
Wang SJ, Cao DL, Xu HW, et al: Development of primary diffuse large b-cell lymphoma around an internal fixation implant after lumbar fusion surgery: a case report and review of the literature. World Neurosurg 137: 140, 2020.
Wang SB, Chen JY, Zhao WL, et al: Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma. Transl Cancer Res 8: 1019, 2019.
Rohlfing S, Aurich M, Schöning T, et al: Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-cell lymphoma and preexisting cardiac diseases. Clin Lymphoma Myeloma Leuk 15: 458, 2015.
Miura K, Takahashi H, Nakagawa M, et al: Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma. Expert Rev Anticancer Ther 22: 583, 2022.
Adams HJA, Nievelstein RAJ, Kwee TC: Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol 170: 185, 2015.
Camus V, Belot A, Oberic L, et al: Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial. Blood Adv 6: 6169, 2022.
Phan J, Mazloom A, Medeiros LJ, et al: Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28: 4170, 2010.
Moccia AA, Schaff K, Freeman C, et al: Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines. Blood Adv 5: 1483, 2021.
Afolayan-Oloye O, Zhao L, Tejasvi T, et al: CD30 expression in cutaneous B-cell lymphomas. J Cutan Pathol 50: 819, 2023.
Primary cutaneous diffuse large B-cell lymphoma, leg type is a type of non-Hodgkin lymphoma. It is a fast-growing and aggressive cancer, therefore early diagnosis and treatment is crucial. It is a cutaneous lymphoma that secondarily invades and involves the bone as it progresses. It has been reported in the calcaneus, tarsal bones, lesser metatarsals, and ankle. Herein we present a case of primary cutaneous diffuse large B-cell lymphoma, leg type that was diagnosed from a metatarsal bone biopsy.